amyloid
2 stories
-
healthBlood Test May Flag Alzheimer's Risk Years Before Symptoms
A new UCSF study links Alzheimer's blood proteins to subtle cognitive decline. Early detection could open a window for intervention.
-
healthHealth Canada Approves Second Drug to Slow Alzheimer's Progression
Donanemab, approved in Canada, offers hope by slowing early Alzheimer's decline, targeting amyloid plaques.